Symbol | Exchange | Currency |
|---|
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Sell |
| Technical Indicators | Buy | Buy | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,251.43 | 2,357.13 | 2,248.88 | -81.02 | -3.47% | 1.41M | NASDAQ | |||
| 136.94 | 138.78 | 136.57 | -1.33 | -0.96% | 982.27K | NYSE | |||
| 1.42 | 1.54 | 1.41 | -0.090 | -5.96% | 4.46M | NASDAQ | |||
| 13.73 | 14.19 | 13.71 | -0.30 | -2.14% | 84.52K | NASDAQ | |||
| 219.90 | 221.63 | 218.25 | +2.69 | +1.24% | 476.57K | NASDAQ | |||
| 106.97 | 109.93 | 106.90 | -2.11 | -1.93% | 4.16M | NYSE | |||
| 33.51 | 35.54 | 33.28 | -1.26 | -3.62% | 381.83K | NASDAQ | |||
| 103.96 | 108.88 | 103.74 | -2.96 | -2.77% | 544.90K | NYSE | |||
| 47.34 | 48.35 | 46.90 | -0.63 | -1.31% | 3.41M | NYSE | |||
| 142.19 | 149.79 | 140.95 | -3.17 | -2.18% | 3.85M | NASDAQ | |||
| 11.44 | 11.45 | 10.73 | +0.320 | +2.88% | 382.19K | NYSE | |||
| 2.61 | 2.87 | 2.57 | -0.21 | -7.45% | 9.60M | NYSE | |||
| 33.22 | 33.87 | 32.58 | +0.48 | +1.47% | 5.85M | NYSE | |||
| 1.47 | 1.50 | 1.365 | +0.080 | +5.76% | 1.73M | NASDAQ | |||
| 124.38 | 131.33 | 122.28 | -5.31 | -4.09% | 1.62M | NYSE |